DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Cervical
Cancer Diagnostic Market Analysis By Test Type (Pap Testing Or Cytology
Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy) And
Segment Forecasts To 2024” report to their offering.
The global cervical cancer diagnostic market was valued at USD 7 billion
in 2015 and is expected to reach a value of USD 12 billion by 2024. The
key driving factors include the rising prevalence of cervical cancer,
evolving screening technology, and various programs that promote routine
check up and screening. According to the data published by the WHO, in
2012, over 270,000 women died due to cervical cancer, majority of which
were from the developing countries. It is one of the most common cancer
type diagnosed in women. Some of the etiological factors are multiple
sex partners, and changing lifestyle, such as drinking & smoking and
increased stress levels.
Furthermore, favorable government initiatives and increasing number of
awareness programs are further expected to promote the market growth in
coming few years. The National Cervical Cancer Coalition, WHO, CDC, the
U.S. Preventive Services Task Force, are working towards promoting the
necessity for early screening of cervical cancer amongst mid aged women.
This market is presently dominated by a few key participants such as
Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Abbott
Laboratories, OncoHealth Corp, Hologic, Inc., QIAGEN, Quest Diagnostics,
Inc and Guided Therapeutics, Inc. The key players focus specially on
developing innovative solutions for diagnosis. For instance, F.
Hoffmann-La Roche Ltd., in 2014, launched automated CINtec PLUS cytology
test that efficiently detects the presence of precancerous cells.
1 Executive Summary
2 Market Snapshot
3 Market Variables, Trends & Scope
4 Market Categorization 1: Test Type Estimates & Trend Analysis
5 Market Categorization 2: Regional Estimates & Trend Analysis
6 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/j7bm8z/cervical_cancer
Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716